» Articles » PMID: 22509241

The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization

Abstract

The importance of innate immune cells in HIV-1 pathogenesis and protection has been highlighted by the role of natural killer (NK) cells in the containment of viral replication. Use of peripheral blood mononuclear cells (PBMC) in immunologic studies provides both HIV-1 target cells (ie. CD4+ T cells), as well as anti-HIV-1 effector cells, such as NK cells. In this study, NK and other immune cell populations were analyzed in HIV-negative donor PBMC for an impact on the anti-HIV activity of polyclonal and monoclonal antibodies. NK cell percentages were significantly higher in donor PBMC that supported lower levels of viral replication. While the percentage of NK cells was not directly associated with neutralization titers, NK cell-depletion significantly diminished the antiviral antibody activity by up to three logs, and polymorphisms in NK killer immunoglobulin receptor (KIR) and FcγRIIIa alleles appear to be associated with this affect. These findings demonstrate that NK cells and NK cell receptor polymorphisms may influence assessment of traditional HIV-1 neutralization in a platform where antibody is continuously present. This format appears to simultaneously assess conventional entry inhibition (neutralization) and non-neutralizing antibody-dependent HIV inhibition, which may provide the opportunity to delineate the dominant antibody function(s) in polyclonal vaccine responses.

Citing Articles

Distinctive Responses in an In Vitro Human Dendritic Cell-Based System upon Stimulation with Different Influenza Vaccine Formulations.

Tapia-Calle G, Stoel M, De Vries-Idema J, Huckriede A Vaccines (Basel). 2017; 5(3).

PMID: 28792466 PMC: 5620552. DOI: 10.3390/vaccines5030021.


Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers.

Joachim A, Munseri P, Nilsson C, Bakari M, Aboud S, Lyamuya E AIDS Res Hum Retroviruses. 2016; 33(8):880-888.

PMID: 28027665 PMC: 5564012. DOI: 10.1089/AID.2016.0251.


Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene.

OConnell R, Excler J, Polonis V, Ratto-Kim S, Cox J, Jagodzinski L J Infect Dis. 2016; 213(12):1946-54.

PMID: 26908741 PMC: 4878724. DOI: 10.1093/infdis/jiw059.


The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.

Seay K, Khajoueinejad N, Zheng J, Kiser P, Ochsenbauer C, Kappes J J Virol. 2015; 89(18):9559-70.

PMID: 26157126 PMC: 4542360. DOI: 10.1128/JVI.01326-15.


Optimized Replicating Renilla Luciferase Reporter HIV-1 Utilizing Novel Internal Ribosome Entry Site Elements for Native Nef Expression and Function.

Alberti M, Jones J, Miglietta R, Ding H, Bakshi R, Edmonds T AIDS Res Hum Retroviruses. 2015; 31(12):1278-96.

PMID: 26101895 PMC: 4663642. DOI: 10.1089/aid.2015.0074.


References
1.
Alter G, Altfeld M . NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection. J Intern Med. 2008; 265(1):29-42. PMC: 2842208. DOI: 10.1111/j.1365-2796.2008.02045.x. View

2.
Robert-Guroff M, Brown M, Gallo R . HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex. Nature. 1985; 316(6023):72-4. DOI: 10.1038/316072a0. View

3.
Alter G, Rihn S, Walter K, Nolting A, Martin M, Rosenberg E . HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J Virol. 2009; 83(13):6798-805. PMC: 2698561. DOI: 10.1128/JVI.00256-09. View

4.
Spear G, Sullivan B, Landay A, Lint T . Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis. J Virol. 1990; 64(12):5869-73. PMC: 248749. DOI: 10.1128/JVI.64.12.5869-5873.1990. View

5.
Koup R, Graham B, Douek D . The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors. Nat Rev Immunol. 2010; 11(1):65-70. DOI: 10.1038/nri2890. View